Rani Therapeutics Holdings, Inc. (RANI) tiene un P/E histórico negativo de -3.9, lo que significa que la empresa actualmente no es rentable en base a los últimos doce meses (TTM). El rendimiento de ganancias histórico es -25.95%.
Criterios demostrados por esta página:
Puntuación General SharesGrow: 56/100 con 3/7 criterios aprobados.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendimiento por Dividendo |
|---|---|---|---|---|---|
| 2019 | -7.7 | 0.00 | -2.13 | 210.55 | - |
| 2020 | -12.3 | 0.33 | -1.82 | 446.16 | - |
| 2021 | -38.3 | 0.76 | 6.74 | 117.55 | - |
| 2022 | -4.6 | -0.02 | 3.81 | 0.00 | - |
| 2023 | -2.5 | -0.64 | 6.58 | 0.00 | - |
| 2024 | -1.3 | 0.06 | 19.58 | 37.95 | - |
| 2025 | -3.0 | 0.05 | 2.70 | 54.68 | - |
| Year | EPS (Diluido) | Ingresos | Ingreso Neto | Margen Neto |
|---|---|---|---|---|
| 2019 | $-1.35 | $979K | $-26.6M | -2716.8% |
| 2020 | $-0.85 | $462K | $-16.7M | -3615.4% |
| 2021 | $-2.69 | $2.72M | $-53.09M | -1953.9% |
| 2022 | $-2.66 | $0.00 | $-63.34M | - |
| 2023 | $-1.33 | $0.00 | $-33.97M | - |
| 2024 | $-1.05 | $1.03M | $-30.02M | -2920% |
| 2025 | $-0.45 | $1.63M | $-29.67M | -1817.1% |
| Year | EPS (Prom.) | Rango EPS | Ingresos (Prom.) | Rango de Ingresos | Analistas |
|---|---|---|---|---|---|
| 2026 | $-0.22 | $-0.27 – $-0.16 | $9M | $8.69M – $9.31M | 2 |
| 2027 | $-0.21 | $-0.24 – $-0.17 | $17.15M | $16.16M – $18.13M | 3 |
| 2028 | $-0.22 | $-0.23 – $-0.21 | $24.4M | $23.56M – $25.23M | 2 |
| 2029 | $-0.26 | $-0.27 – $-0.24 | $26.75M | $25.82M – $27.66M | 1 |
| 2030 | $-0.04 | $-0.04 – $-0.03 | $88M | $84.95M – $91M | 1 |
